Lactobacillus fermentum ATCC 23271 Displays In vitro Inhibitory Activities against Candida spp.
- 2016-10-27
- Frontiers in Microbiology 7
- Monique S do Carmo
- Francisca M. F. Noronha
- M. O. Arruda
- E. P. Costa
- M. Bomfim
- A. Monteiro
- T. Ferro
- E. Fernandes
- J. Girón
- V. Monteiro-Neto
- PubMed: 27833605
- DOI: 10.3389/fmicb.2016.01722
- Low evidence
Collectively, our data suggest that L. fermentum ATCC 23271 is a potential probiotic candidate, particularly to complement candidiasis treatment, since presented with the best probiotic profile in comparison with the other tested lactobacilli strains.
- Effect
- Beneficial
- Effect size
- Moderate